Analyzing Accounts Receivable Lupin Pharmaceuticals, an Indian transnational pharmaceutical company, develops and markets a wide portfolio of branded and generic products. The company reported the following in its 2018 annual report. INR millions 2018 2017 2016 Trade receivables 545.961.5 538,184.8 540432.7 Less provision for doubtful receivables 306.9 318.4 Trade receivables, net 545.654.6 537866.4 539.984.5 Totalasses 5140958 $146.566 5127,375 Revenue from operations 158,042 174943 142.555 Required a Calculate days sale outstanding (DSO) for 2018 and 2017 Note: Round amount your final answer to one decimal place (for example, enter 6.8 for 6.77555). OSO for 2018 os for 2017 972 x days Oxdays